Published Date: August 10, 2019

Full Text Article

ANO5 mutations in the Polish limb girdle muscular dystrophy patients: Effects on the protein structure


Authors: Adam Jarmula, Anna Łusakowska, Jakub P Fichna, Malgorzata Topolewska, Anna Macias, Katherine Johnson, Ana Töpf, Volker Straub, Edyta Rosiak, Krzysztof Szczepaniak, Stanisław Dunin-Horkawicz, Aleksandra Maruszak, Anna M Kaminska, Maria Jolanta Redowicz


Sci Rep. 2019 Aug 8;9(1):11533. doi: 10.1038/s41598-019-47849-3.

ABSTRACT

LGMD2L is a subtype of limb-girdle muscular dystrophy (LGMD), caused by recessive mutations in ANO5, encoding anoctamin-5 (ANO5). We present the analysis of five patients with skeletal muscle weakness for whom heterozygous mutations within ANO5 were identified by whole exome sequencing (WES). Patients varied in the age of the disease onset (from 22 to 38 years) and severity of the morphological and clinical phenotypes. Out of the nine detected mutations one was novel (missense p.Lys132Met, accompanied by p.His841Asp) and one was not yet characterized in the literature (nonsense, p.Trp401Ter, accompanied by p.Asp81Gly). The p.Asp81Gly mutation was also identified in another patient carrying a p.Arg758Cys mutation as well. Also, a c.191dupA frameshift (p.Asn64LysfsTer15), the first described and common mutation was identified. Mutations were predicted by in silico tools to have damaging effects and are likely pathogenic according to criteria of the American College of Medical Genetics and Genomics (ACMG). Indeed, molecular modeling of mutations revealed substantial changes in ANO5 conformation that could affect the protein structure and function. In addition, variants in other genes associated with muscle pathology were identified, possibly affecting the disease progress. The presented data indicate that the identified ANO5 mutations contribute to the observed muscle pathology and broaden the genetic spectrum of LGMD myopathies.

PMID: 31395899DOI: 10.1038/s41598-019-47849-3PMC: PMC6687736